ArticleJournal of psychiatry & neuroscience : JPN
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.
Abstract read
In one paragraph
Article in Journal of psychiatry & neuroscience : JPN. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.Journal of psychopharmacology (Oxford, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Michel SabéDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Federico SeragnoliDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Gabriel ThorensDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Daniele ZullinoDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Othman SentissiDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Marco SolmiDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Kerem BögeDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Stefan KaiserDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Matthias KirschnerDivision of Adult Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Thonex, Switzerland (Sabé, Sentissi, Kaiser, Kirschner); Faculty of Medicine, University of Geneva, Geneva, Switzerland (Sabé, Thorens, Zullino, Sentissi, Kaiser, Kirschner); Division of Addiction Psychiatry, Department of Psychiatry, University Hospitals of Geneva, Geneva, Switzerland (Seragnoli, Thorens, Zullino); Department of Psychiatry, University of Ottawa (Solmi); Department of Mental Health, The Ottawa Hospital (Solmi); Ottawa Hospital Research Institute Clinical Epidemiology Program, University of Ottawa, Ottawa, Ont. (Solmi); Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany (Solmi); Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin; and Freie Universität Berlin; and Humboldt-Universität zu Berlin (Böge); Berlin Institute of Health (Böge); German Center of Mental Health (DZPG), Berlin, Germany (Böge); Medical University Brandenburg - Theodor Fontane, Neuruppin, Germany (Böge).
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.